Axxcess Wealth Management LLC Grows Stake in Haleon plc (NYSE:HLN)

Axxcess Wealth Management LLC increased its position in shares of Haleon plc (NYSE:HLN) by 138.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 44,824 shares of the company’s stock after buying an additional 25,988 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Haleon were worth $381,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. EP Wealth Advisors LLC increased its position in Haleon by 26.1% during the first quarter. EP Wealth Advisors LLC now owns 22,573 shares of the company’s stock worth $192,000 after buying an additional 4,679 shares during the period. Pitcairn Co. increased its position in Haleon by 52.9% during the first quarter. Pitcairn Co. now owns 174,413 shares of the company’s stock worth $1,481,000 after buying an additional 60,319 shares during the period. Lake Street Advisors Group LLC increased its position in Haleon by 61.5% during the first quarter. Lake Street Advisors Group LLC now owns 22,884 shares of the company’s stock worth $198,000 after buying an additional 8,715 shares during the period. Clearbridge Investments LLC increased its position in Haleon by 44.6% during the first quarter. Clearbridge Investments LLC now owns 38,446,978 shares of the company’s stock worth $326,415,000 after buying an additional 11,865,076 shares during the period. Finally, O Shaughnessy Asset Management LLC increased its position in Haleon by 94.0% during the first quarter. O Shaughnessy Asset Management LLC now owns 43,766 shares of the company’s stock worth $372,000 after buying an additional 21,202 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Performance

Shares of NYSE:HLN traded up $0.09 during trading on Friday, reaching $9.23. The company had a trading volume of 6,835,187 shares, compared to its average volume of 3,703,862. The firm has a market capitalization of $42.15 billion, a price-to-earnings ratio of 30.75, a price-to-earnings-growth ratio of 2.63 and a beta of 0.24. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The stock’s fifty day moving average price is $8.56 and its 200 day moving average price is $8.41. Haleon plc has a fifty-two week low of $7.70 and a fifty-two week high of $9.28.

Haleon (NYSE:HLN) last released its earnings results on Wednesday, May 1st. The company reported $0.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.01. Haleon had a return on equity of 13.17% and a net margin of 9.68%. The business had revenue of $3.70 billion for the quarter, compared to analyst estimates of $3.71 billion. As a group, equities research analysts predict that Haleon plc will post 0.47 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Berenberg Bank assumed coverage on Haleon in a report on Wednesday, June 5th. They issued a “buy” rating on the stock. HSBC assumed coverage on Haleon in a report on Wednesday, April 17th. They issued a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.